Items where authors include "Ottewell, P."

Export as [feed] Atom [feed] RSS
Number of items: 9.

Article

Clezardin, P. orcid.org/0000-0003-0149-4463, Coleman, R., Puppo, M. et al. (5 more authors) (2021) Bone metastasis : mechanisms, therapies and biomarkers. Physiological Reviews, 101 (3). pp. 797-855. ISSN 0031-9333

George, C.N., Canuas-Landero, V., Theodoulou, E. et al. (3 more authors) (2020) Oestrogen and zoledronic acid driven changes to the bone and immune environments: potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions. Journal of Bone Oncology, 25. 100317. ISSN 2212-1374

Lefley, D., Howard, F., Arshad, F. et al. (9 more authors) (2019) Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts. Breast Cancer Research, 21 (1). 130. ISSN 1465-5411

Ottewell, P. orcid.org/0000-0002-4826-0771 and Wilson, C. (2019) Bone-targeted agents in breast cancer : do we now have all the answers? Breast Cancer: Basic and Clinical Research, 13.

Holen, I. orcid.org/0000-0002-8759-6913, Lefley, D.V., Francis, S.E. et al. (4 more authors) (2016) IL-1 drives breast cancer growth and bone metastasis in vivo. Oncotarget, 7. pp. 75571-75584. ISSN 1949-2553

Wilson, C., Ottewell, P., Coleman, R.E. et al. (1 more author) (2015) The differential anti-tumour effects of zoledronic acid in breast cancer - evidence for a role of the activin signaling pathway. BMC Cancer, 15. 55. ISSN 1471-2407

Proceedings Paper

Canuas-Landero, V., George, C., Lefley, D. et al. (2 more authors) (2021) Interactions between oestradiol and zoledronic acid in the bone microenvironment; physiological changes altering metastatic potential of breast cancer cells in pre- and post-menopausal women. In: Bone Reports. 48th European Calcified Tissue Society Congress ECTS 2021, 06-08 May 2021, Virtual conference. Elsevier BV .

Bishop, N. orcid.org/0000-0001-7263-8546, Kalajzic, I., Arshad, F. orcid.org/0000-0002-3685-859X et al. (3 more authors) (2019) Losartan reduces circulating TGFb and CTX and increases vertebral bone mass in the OIM mouse. In: Bone Abstracts. 9th International Conference on Children’s Bone Health, 22-25 Jun 2019, Salzburg, Austria. Bioscientifica .

Lefley, D., Nutter, F., Brown, H. et al. (7 more authors) (2017) Human specific models for studying ER plus ve and ER- ve breast cancer bone metastasis. In: Clinical and Experimental Metastasis. EACR seed and soil: in vivo models of metastasis conference, 27-29 Nov 2017, Berlin, Germany . Springer Verlag , p. 516.

This list was generated on Sun Apr 14 10:54:53 2024 BST.